Evidence map›Paper›PMID 38173214›Full record

ArticleCurrent computer-aided drug design2024

Identify Diabetes-related Targets based on ForgeNet_GPC.

Bin Yang, Linlin Wang, Wenzheng Bao

Abstract read
PubMed Publisher
In one paragraph

Article in Current computer-aided drug design, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Bin YangSchool of Information Science and Engineering, Zaozhuang University, Zaozhuang, 277160, China.
Linlin WangSchool of Information Science and Engineering, Zaozhuang University, Zaozhuang, 277160, China.
Wenzheng BaoSchool of Information and Electrical Engineering, Xuzhou University of Technology, Xuzhou, 221018, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundResearch on potential therapeutic targets and new mechanisms of action can greatly improve the efficiency of new drug development.

aimsPolygenic genetic diseases, such as diabetes, are caused by the interaction of multiple gene loci and environmental factors.

objectivesIn this study, a disease target identification algorithm based on protein recognition is proposed. MATERIALS AND

methodsIn this method, the related and unrelated targets are collected from literature databases for treating diabetes. The transcribed proteins corresponding to each target are queried in order to construct a protein dataset. Six protein feature extraction algorithms (AAC, CKSAAGP, DDE, DPC, GAAP, and TPC) are utilized to obtain the feature vectors of each protein, which are merged into the full feature vectors.

resultsA novel classifier (forgeNet_GPC) based on forgeNet and Gaussian process classifier (GPC) is proposed to classify the proteins.

conclusionIn forgeNet_GPC, forgeNet is utilized to select the important features, and GPC is utilized to solve the classification problem. The experimental results reveal that forgeNet_GPC performs better than 22 classifiers in terms of ROC-AUC, PR-AUC, MCC, Youden Index, and Kappa.

Indexed as

AlgorithmsDiabetes MellitusHumansHypoglycemic AgentsMolecular Targeted TherapyProteinsHypoglycemic AgentsProteinsclassificationdiabetesfeature extractionpolygenic genetic diseases.Proteintarget

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.